EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Coeptis Therapeutics Holdings, Inc. (COEP) EBITDA Margin data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-10.88M |
|
-- |
|
-- |
|
$10.05M |
|
$-10.05M |
|
$-0.82M |
|
$-10.88M |
|
$-10.84M |
|
$-10.88M |
|
$-10.88M |
|
$-10.88M |
|
$-10.84M |
|
$-10.05M |
|
$-8.84M |
|
1.93M |
|
1.93M |
|
$-5.65 |
|
$-5.65 |
|
| Balance Sheet Financials | |
$1.05M |
|
$0.01M |
|
$7.86M |
|
$8.91M |
|
$4.51M |
|
$0.15M |
|
$0.53M |
|
$5.04M |
|
$3.87M |
|
$3.33M |
|
$3.87M |
|
2.12M |
|
| Cash Flow Statement Financials | |
$-6.65M |
|
-- |
|
$5.71M |
|
$1.47M |
|
$0.53M |
|
$-0.94M |
|
$2.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.23 |
|
-- |
|
-- |
|
0.04 |
|
0.35 |
|
-- |
|
-- |
|
-- |
|
|
EBITDA Margin |
-- |
-- |
|
-- |
|
$-6.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-281.27% |
|
-327.11% |
|
-122.10% |
|
-270.77% |
|
$1.83 |
|
$-3.45 |
|
$-3.45 |
|